BANCR
gene geneOn this page
Also known as LINC00586
Summary
BANCR (BRAF-activated non-protein coding RNA, HGNC:43877) is a long non-coding RNA gene on chromosome 9q21.11-q21.12.
This gene produces a long non-coding RNA that plays a role in tumor progression and epithelial to mesenchymal transition. This transcript acts through the MAP kinase signaling pathway.
Source: NCBI Gene 100885775 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43877 |
| Approved symbol | BANCR |
| Name | BRAF-activated non-protein coding RNA |
| Location | 9q21.11-q21.12 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | LINC00586 |
| Ensembl gene | ENSG00000278910 |
| Ensembl biotype | lncRNA |
| OMIM | 619589 |
| Entrez | 100885775 |
| RNAcentral | URS0000759AA6 — lncRNA, 688 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 lncRNA
ENST00000624238, ENST00000625062, ENST00000690153, ENST00000691130, ENST00000693755, ENST00000787798, ENST00000787799, ENST00000787800, ENST00000787801, ENST00000787802, ENST00000787803
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000624238 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003755980 | 69304936 | 69305077 |
| ENSE00003758077 | 69306148 | 69306290 |
| ENSE00004165703 | 69306854 | 69307181 |
| ENSE00004165707 | 69296671 | 69296867 |
Expression profiles
Bgee: expression breadth ubiquitous, 123 present calls, max score 84.96.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1820 / max 76.6168, expressed in 40 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 100803 | 0.1585 | 35 |
| 100804 | 0.0235 | 5 |
Top tissues by expression
222 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.96 | gold quality |
| buccal mucosa cell | CL:0002336 | 81.50 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 77.71 | gold quality |
| heart left ventricle | UBERON:0002084 | 75.02 | gold quality |
| cardiac ventricle | UBERON:0002082 | 74.92 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 71.93 | gold quality |
| heart right ventricle | UBERON:0002080 | 69.51 | gold quality |
| myocardium | UBERON:0002349 | 69.25 | silver quality |
| heart | UBERON:0000948 | 68.83 | gold quality |
| kidney epithelium | UBERON:0004819 | 67.56 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 65.41 | gold quality |
| sperm | CL:0000019 | 65.18 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 63.20 | gold quality |
| apex of heart | UBERON:0002098 | 62.78 | gold quality |
| islet of Langerhans | UBERON:0000006 | 61.01 | gold quality |
| right atrium auricular region | UBERON:0006631 | 59.45 | gold quality |
| right lung | UBERON:0002167 | 59.20 | gold quality |
| cardiac atrium | UBERON:0002081 | 58.85 | gold quality |
| secondary oocyte | CL:0000655 | 58.62 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 56.38 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 56.19 | silver quality |
| pancreatic ductal cell | CL:0002079 | 55.86 | silver quality |
| left lobe of thyroid gland | UBERON:0001120 | 55.80 | gold quality |
| deltoid | UBERON:0001476 | 55.60 | gold quality |
| quadriceps femoris | UBERON:0001377 | 55.54 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 55.49 | gold quality |
| biceps brachii | UBERON:0001507 | 55.04 | gold quality |
| thyroid gland | UBERON:0002046 | 55.01 | gold quality |
| tibialis anterior | UBERON:0001385 | 54.60 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.25 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 30)
- The lncRNA BRAF-activated non-protein coding RNA (BANCR) was upregulated in EoE and induced in interleukin-13 (IL-13)-treated primary esophageal epithelial cells. (PMID:24920534)
- BANCR levels were downregulated in lung carcinoma cells. (PMID:25661343)
- In conclusion, lncRNA BANCR plays a significant role in retinoblastoma aggressiveness and prognosis and may act as a promising target for therapeutic strategy and prognostic prediction. (PMID:25894373)
- findings suggest that down-regulation of BANCR contributes to the proliferation of colorectal cancer cells, at least in part, through the regulation of p21 protein. (PMID:25928067)
- high expression of BANCR was an independent unfavorable prognostic factor in gastric cancer patients. (PMID:26054683)
- BANCR was highly expressed both in gastric tumor tissues and in cancer cells. NF-kappaB1 and miR-9 were involved in BANCR-mediated gastric cancer cell growth and apoptosis. (PMID:26248136)
- Fentanyl showed anti-tumor like effects on CRC cells, including less cell clone formation and inhibited cell migration and invasion. (PMID:26296467)
- BANCR inhibits tumorigenesis in papillary thyroid carcinoma and that BANCR levels may be used as a novel prognostic marker. (PMID:27462868)
- BANCR may be a novel tumor biomarker for early detection, a prospective prognostic indicator and a potential therapeutic target for Esophageal squamous cell cancer. (PMID:27470379)
- Study shows that lncRNA BANCR is decreased in bladder cancer tissues and correlates with advanced TNM stage and suggest that BANCR is a tumor suppressor player in bladder cancer which contributes to tumor proliferation, apoptosis and migration. (PMID:27514530)
- BANCR is highly expressed in type 1 endometrial cancer (EC) tissue and promotes EC-cell proliferation, migration, and invasion by activating ERK/MAPK signaling pathway that regulates MMP2/MMP1 expression. (PMID:27898420)
- Review/Meta-analysis: BANCR as a promising prognostic biomarker in Chinese patients with gastrointestinal cancer. (PMID:28009984)
- Upregulation of lncRNA BANCR may be associated with the lymph node metastasis and poor survival of colorectal. LncRNA BANCR could be served as a novel and useful biomarker for colorectal lymph node metastasis and prognosis. (PMID:28969673)
- BANCR expression induced by IFN-gamma was suppressed when STAT1 phosphorylation was blocked by JAK inhibitor 1. (PMID:29054724)
- BANCR may promote melanoma cell growth through inhibition of miR204, leading to the activation of Notch2 pathway. Authors further demonstrated that BANCR knockdown inhibited tumor growth in vivo. Results suggest the BANCR/miR204/Notch2 axis mediates melanoma cell proliferation and tumor progression. (PMID:29075789)
- BANCR plays a role in PTC development. (PMID:29917164)
- These results suggest a possible role of lncRNA-BANCR in proliferation of esophageal tissues and may be considered as a potential prognostic value for Esophageal squamous cell carcinoma metastasis. (PMID:30552615)
- Transfection with the BANCR expression vector significantly inhibited proliferation and promoted apoptosis of KGN cells, and significantly promoted the expression levels of proapoptotic Bax and p53. Therefore, it may be concluded that lncRNA BANCR participates in PCOS by promoting cell apoptosis through the upregulation of Bax and p53. (PMID:30592281)
- lncRNA BANCR is overexpressed in patients with diabetic retinopathy and can promote apoptosis of retinal pigment epithelial cells. (PMID:30996220)
- We found IFN-gamma gene (rs2069705 and rs2430561), and 2 variants in lncRNA BANCR (rs6559446 and rs79823312) could increase coronary artery disease (CAD) susceptibility in allelic and dominant model, while IFN-gamma rs2069705 and rs2430561, BANCR rs79823312 were also associated with CAD risk in additive model. IFN-gamma rs2069705 and rs2430561 were associated with higher level of serum IFN-gamma in CAD patients (PMID:31141710)
- Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/beta-catenin Pathway In Vitro and In Vivo. (PMID:31482398)
- High BANCR expression is associated with metastasis in cancer (meta analysis). (PMID:31983132)
- BRAF(V600E) mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features. (PMID:32593310)
- Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation. (PMID:32651027)
- High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis. (PMID:32907530)
- Long noncoding RNA BANCR mediates esophageal squamous cell carcinoma progression by regulating the IGF1R/Raf/MEK/ERK pathway via miR3383p. (PMID:32945416)
- Comparison of therapeutic effects of ticagrelor and clopidogrel on patients with acute myocardial infarction and influence of lncRNA BANCR. (PMID:33336751)
- Long noncoding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway. (PMID:33880577)
- lncRNA BANCR promotes the colorectal cancer metastasis through accelerating exosomes-mediated M2 macrophage polarization via regulating RhoA/ROCK signaling. (PMID:36988779)
- LncRNA BANCR promotes oral squamous cell carcinoma progression via regulating Rab1A signaling. (PMID:37433101)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.